☆ 4.7 Meeting Abstract

Using CVD risk scores to select between GLP-1RA or SGLT2i therapy in type 2 diabetes: modelling the combined effects on both major atherosclerotic and heart failure events

DIABETOLOGIA (2022)

Add to Collection

Journal

DIABETOLOGIA
Volume 65, Issue SUPPL 1, Pages S418-S419

Publisher

SPRINGER

Keywords

-

Categories

Endocrinology & Metabolism

Funding

  1. NHMRC
  2. Victorian Government

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.